Medical research at Dundee University has been given a £24 million boost.
A five-year funding package will allow scientists to expand their work on understanding and treating diseases such as cancer, Parkinson’s, immune disorders and hypertension.
The protein phosphorylation and ubiquitylation unit will also be able to recruit more researchers, adding to the 162 staff it already boasts.
The money is coming from the Medical Research Council and cements the university’s reputation as one of the UK’s leading centres for life sciences.
Phosphorylation and ubiquitylation are processes that change the properties and functions of proteins within the cells that make up the body.
“Abnormalities in these processes lead to cancer, neurodegeneration and inflammation.
Working out exactly how this happens is key to coming up with new drugs.
Unit head Professor Dario Alessi said: “Our ability to expand into the ubiquitylation research areas and to recruit additional researchers will greatly boost our links with the pharmaceutical industry.”
